Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Marketed antibiotics can induce mitochondrial dysfunction by inhibiting mitochondrial translation.
• Exploiting antibiotic-induced mitochondrial dysfunction is a promising strategy for cancer therapy.
• Enhancing antibiotic accumulation within cancer cell mitochondria can increase therapeutic potency.

Purpose of the Study:

• To develop novel mitochondria-targeting antibiotic derivatives for cancer treatment.
• To investigate the efficacy of triphenylphosphonium (TPP)-conjugated azithromycin and doxycycline in cancer cells.
• To evaluate the impact of these conjugates on mitochondrial function and cell viability.

Main Methods:

• Synthesis of azithromycin and doxycycline derivatives conjugated with a triphenylphosphonium (TPP) cation via alkyl chains of varying lengths (7-11 carbons).
• Utilizing MDA-MB-231 cancer cell line for in vitro studies.
• Assessing the effects of the synthesized compounds on mitochondrial translation, mitochondrial bioenergetics, and overall cell viability.

Main Results:

• The TPP-conjugated antibiotics demonstrated enhanced accumulation within cancer cell mitochondria.
• Inhibition of mitochondrial translation was observed in cells treated with the TPP-antibiotic conjugates.
• Modulation of mitochondrial bioenergetics and significant impact on cancer cell viability were noted.

Conclusions:

• Triphenylphosphonium (TPP) conjugation is an effective strategy to enhance mitochondrial targeting of antibiotics.
• Modified antibiotics show potential for cancer therapy by disrupting mitochondrial function.
• Further investigation into these TPP-antibiotic conjugates could lead to novel cancer treatment modalities.